Genelux GNLX
NASDAQ GNLX
$2.72 -0.02 (-0.73%)
At close: Aug 21, 2026 · 4:00 PM EDT

Genelux (GNLX) Net Income (2022 - 2026)

Genelux (GNLX) posted quarterly Net Income of -$9.3 million for Q1 2026, down 21.02% year-over-year from -$11.8 million in Q1 2025, and up 38.38% quarter-over-quarter from -$15.1 million in Q4 2025.

Genelux (GNLX) Net Income (2022 - 2026) Analysis & Trends

Genelux's Net Income history runs 5 years deep, the most recent figure standing at -$9.3 million for Q1 2026.

  • In Q1 2026, Net Income fell 21.02% year-over-year to -$9.3 million; the TTM figure through Mar 2026 stood at -$43.8 million (down 42.33% YoY), while the FY2025 annual figure was -$111.0 million, down 21.05% from the prior year.
  • Net Income for Q1 2026 stood at -$9.3 million, up from -$15.1 million in the prior quarter.
  • The five-year high for Net Income was $4.9 million in Q3 2022, with the low at -$117.2 million in Q2 2023.
  • The 5-year median for Net Income is -$8.1 million (2025), against an average of -$14.8 million.
  • The sharpest annual moves came in 2023 and 2024: Net Income tumbled 208.88% in 2023, then surged 94.26% in 2024.
  • Genelux's Net Income stood at -$3.5 million in 2022, then slumped by 93.62% to -$6.8 million in 2023, then plunged by 39.78% to -$9.5 million in 2024, then sank by 60.13% to -$15.1 million in 2025, then soared by 38.38% to -$9.3 million in 2026.
  • Business Quant data shows GNLX's Net Income at -$9.3 million in Q1 2026, -$15.1 million in Q4 2025, and -$11.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.10 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 1.30 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 482.00 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -782.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 237.01 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 164.49 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -355.03 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -13.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 81.49 Mn
10 Genelux 119.87 Mn 119.87 Mn - -9.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -9.33 Mn
Dec 31, 2025 -15.15 Mn
Sep 30, 2025 -11.28 Mn
Jun 30, 2025 -8.06 Mn
Mar 31, 2025 -7.71 Mn
Dec 31, 2024 -9.46 Mn
Sep 30, 2024 -6.89 Mn
Jun 30, 2024 -6.73 Mn
Mar 31, 2024 -9.50 Mn
Dec 31, 2023 -6.77 Mn
Sep 30, 2023 -5.35 Mn
Jun 30, 2023 -117.16 Mn
Mar 31, 2023 -9.57 Mn
Dec 31, 2022 -3.50 Mn
Sep 30, 2022 4.91 Mn